19-35848334-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM1PM5
The NM_004646.4(NPHS1):c.1234G>A(p.Gly412Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000026 in 1,614,056 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G412C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_004646.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital nephrotic syndrome, Finnish typeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, G2P, Labcorp Genetics (formerly Invitae), ClinGen
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NPHS1 | ENST00000378910.10 | c.1234G>A | p.Gly412Ser | missense_variant | Exon 10 of 29 | 1 | NM_004646.4 | ENSP00000368190.4 | ||
| NPHS1 | ENST00000353632.6 | c.1234G>A | p.Gly412Ser | missense_variant | Exon 10 of 28 | 5 | ENSP00000343634.5 | |||
| NPHS1 | ENST00000592132.1 | n.241G>A | non_coding_transcript_exon_variant | Exon 3 of 4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152080Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000517 AC: 13AN: 251346 AF XY: 0.0000736 show subpopulations
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461858Hom.: 0 Cov.: 31 AF XY: 0.0000358 AC XY: 26AN XY: 727238 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74414 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: NPHS1 c.1234G>A (p.Gly412Ser) results in a non-conservative amino acid change located in the CD80-like, immunoglobulin C2-set domain (IPR013162) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.2e-05 in 251346 control chromosomes (gnomAD). This frequency is not significantly higher than expected for a pathogenic variant in NPHS1 causing Nephrotic Syndrome, Type 1 (5.2e-05 vs 0.0034), allowing no conclusion about variant significance. c.1234G>A has been reported in the literature in a compound heterozygous individual affected with Steroid-resistant nephrotic syndrome (SRNS). This report however, does not provide unequivocal conclusions about association of the variant with Nephrotic Syndrome, Type 1. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. However, another nucleotide change affecting the same codon (c.1234G>T p.G412C) has been reported as likely pathogenic in ClinVar. Based on the evidence outlined above, the variant was classified as uncertain significance. -
not provided Uncertain:1
- -
Finnish congenital nephrotic syndrome Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at